Continual lymphocytic leukemia (CLL) can be a lymphoid malignancy characterised through the proliferation and accumulation of mature CD5+ B cells during the blood, bone marrow and lymphoid tissues. The prognosis of CLL calls for the presence of ?5 x109/L mono - clonal B cells of common phenotype in the blood.All this understanding has supplied new